Currently, the first-line drugs for leukopenia treatment include granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF), leucogen, vitamin B4, etc. (Bayne et al., 2012; Tian et al., 2019). The gene discussed is CSF2; the disease is Decreased total leukocyte count.